Terms: = Prostate cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
260 results:
1. Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 prostate cancer Cells.
Mora N; Rosa M; Touaibia M; Martin LJ
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675711
[TBL] [Abstract] [Full Text] [Related]
2. [Research on the anti-tumor effects of CRYAB in prostate cancer].
Zhang CL; Hu Y; Wang DX; Yang Q; Chang DH
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):579-286. PubMed ID: 38619403
[TBL] [Abstract] [Full Text] [Related]
3. A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy.
He Y; Fan Y; Song H; Shen Q; Ruan M; Chen Y; Li D; Li X; Liu Y; Zhang K; Zhang Q
BMC Urol; 2024 Apr; 24(1):85. PubMed ID: 38614971
[TBL] [Abstract] [Full Text] [Related]
4. The Value of
Shi J; Li D; Chen M; Fu Y; Peng S; Zhang Q; Liang J; Lu Q; Lu J; Ai S; Wang F; Qiu X; Guo H
J Nucl Med; 2024 Apr; 65(4):555-559. PubMed ID: 38485278
[TBL] [Abstract] [Full Text] [Related]
5. Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study.
Hao X; Ren C; Zhou H; Li M; Zhang H; Liu X
Front Endocrinol (Lausanne); 2024; 15():1358416. PubMed ID: 38405157
[TBL] [Abstract] [Full Text] [Related]
6. Predictive accuracy of boosted regression model in estimating risk of venous thromboembolism following minimally invasive radical surgery in pharmacological prophylaxis-naïve men with prostate cancer.
Leong CH; Ranjan SR; Javed A; Alsaedi BSO; Nabi G
World J Surg Oncol; 2024 Feb; 22(1):67. PubMed ID: 38395873
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Study of Different Imaging Modalities for Diagnosis of Bone Metastases of prostate cancer: A Bayesian Network Meta-analysis.
Kim K; Ha M; Kim SJ
Clin Nucl Med; 2024 Apr; 49(4):312-318. PubMed ID: 38350066
[TBL] [Abstract] [Full Text] [Related]
8. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Pellegrino F; Stabile A; Sorce G; Mazzone E; Cannoletta D; Cirulli GO; Quarta L; Leni R; Robesti D; Brembilla G; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
Prostate; 2024 Apr; 84(5):473-478. PubMed ID: 38149793
[TBL] [Abstract] [Full Text] [Related]
9. Phenotypic Characterization of 2D and 3D prostate cancer Cell Systems Using Electrical Impedance Spectroscopy.
Crowell LL; Yakisich JS; Aufderheide B; Adams TNG
Biosensors (Basel); 2023 Dec; 13(12):. PubMed ID: 38131796
[TBL] [Abstract] [Full Text] [Related]
10. The influence of prostate volume on pathological outcomes after radical prostatectomy: A single-center retrospective study.
Li Q; Yang Z; Wang Z; Sun J; Wen C; Yan H; Shen H; Wang W; Xu B; Xiang J; Teng X; Zhang C; Zheng X; Xie L
Medicine (Baltimore); 2023 Dec; 102(49):e36526. PubMed ID: 38065843
[TBL] [Abstract] [Full Text] [Related]
11. Orthopaedic surgeons' ability to detect pathologic hip fractures: review of 1484 fractures reported to the Norwegian Hip Fracture Register.
Sund A; Dybvik E; Gjertsen JE
J Orthop Surg Res; 2023 Nov; 18(1):832. PubMed ID: 37925444
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National cancer Database.
Estrada-Mendizabal RJ; Dhaliwal AS; Bertolo AJ; Batai K; Heimark R; Recio-Boiles A; Chipollini J
Clin Genitourin Cancer; 2024 Feb; 22(1):e148-e155.e1. PubMed ID: 37903669
[TBL] [Abstract] [Full Text] [Related]
13. Aridanin and oleanane-3- O-β-D-glucoside-2'-acetamide obtained from Tetrapleura tetraptera (Schumach. & Thonn) Taub. (Fabaceae) induces potent apoptotic activity in human prostate cancer cells.
Kamdem MHK; Zingue S; Grein T; Maxeiner S; Rutz J; Mmutlane EM; Njamen D; Blaheta RA; Ndinteh DT
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117298. PubMed ID: 37866463
[TBL] [Abstract] [Full Text] [Related]
14. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
15. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic prostate cancer.
Camargo JA; Viana NI; Pimenta R; Guimarães VR; Dos Santos GA; Candido P; Ghazarian V; Romão P; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Trarbach EB; Reis ST
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834295
[TBL] [Abstract] [Full Text] [Related]
16. [Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].
Liu Y; Yuan CW; Wu JY; Shen Q; Xiao JX; Zhao Z; Wang XY; Li XS; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):812-817. PubMed ID: 37807733
[TBL] [Abstract] [Full Text] [Related]
17. Effect of Socioeconomic Disparities on Suicide Risk in Patients With prostate cancer During 2005 to 2020: A Population Study.
Jia YJ; Hu FH; Tang W; Zhang WQ; Ge MW; Shen LT; Hu SQ; Shen WQ; Chen HL
Clin Genitourin Cancer; 2024 Apr; 22(2):84-91.e7. PubMed ID: 37758561
[TBL] [Abstract] [Full Text] [Related]
18. Effects of exercise training on cancer patients undergoing neoadjuvant treatment: A systematic review.
Malveiro C; Correia IR; Cargaleiro C; Magalhães JP; de Matos LV; Hilário S; Sardinha LB; Cardoso MJ
J Sci Med Sport; 2023 Nov; 26(11):586-592. PubMed ID: 37696693
[TBL] [Abstract] [Full Text] [Related]
19. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
20. A pilot study of an organised population-based testing programme for prostate cancer.
Alterbeck M; Thimansson E; Bengtsson J; Baubeta E; Zackrisson S; Bolejko A; Sandeman K; Carlsson S; Jiborn T; Bjartell A
BJU Int; 2024 Jan; 133(1):87-95. PubMed ID: 37523331
[TBL] [Abstract] [Full Text] [Related]
[Next]
